Gastric and oesophageal cancer trials in Spain

64 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  138 worldwide

  Run by

  EMD Serono Research & Development Institute, Inc.

  See details and how to joinNCT07360314 · EU 2025-523232-39-00
• Phase 2Not yet taking people in Spain
  Local and Systemic Immune Modulation by Rilvegostomig (AZD2936) in the Treatment of Advanced Gastric Cancer (RILVE Project)

  Where

  Barcelona, Madrid, Pamplona

  Age

  18 years and over

  People

  50

  Run by

  Vall d'Hebron Institute of Oncology

  See details and how to joinNCT07788664 · EU 2026-525620-23-00
• Phase 3Taking people
  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  134 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to join2025-524160-38-00
• Phase 1Taking people
  A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  Where

  Logrono, Madrid, Valencia

  Age

  18 years and over

  People

  150 worldwide

  Run by

  IDEAYA Biosciences

  See details and how to joinNCT07503808 · EU 2026-526299-21-00
• Phase 1Not yet taking people in Spain
  A Study of LY4336619 in Adult Participants With Advanced Solid Tumors

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  370 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07928258 · EU 2026-526553-33-00
• Phase 3Not yet taking people in Spain
  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  Where

  A Coruña, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Palma, Sant Cugat del Vallès, Sevilla, Terrassa, Valencia, Vigo, Zaragoza

  Age

  18 years and over

  People

  570 worldwide

  Run by

  Astellas Pharma Global Development, Inc.

  See details and how to joinNCT07673887 · EU 2025-524557-14-00
• Phase 1/2Taking people
  Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  Where

  A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Seville, Valencia

  Age

  18 years and over

  People

  910 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06324357
• Phase 3Active, not recruiting
  A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  Where

  A Coruña, Badalona, Barcelona, Elche, Lleida, Madrid, Murcia, Pamplona, Pozuelo de Alarcón, Sant Cugat del Vallès, Santiago de Compostela, Sevilla, Terrassa, Valencia, Zaragoza

  Age

  18 years and over

  People

  500 worldwide

  Run by

  Astellas Pharma Global Development, Inc.

  See details and how to joinNCT06901531 · EU 2024-519773-19-00
• Phase 1Taking people
  A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  540 worldwide

  Run by

  Pfizer

  See details and how to joinNCT07090499 · EU 2025-521729-33-00
• Phase 2/3Taking people
  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  Where

  Barcelona, Madrid, Málaga, Pamplona, Santander, Valencia

  Age

  18 years and over

  People

  690 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07221149 · EU 2025-523263-37-00
• Phase 1Taking people
  Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  250 worldwide

  Run by

  Pfizer

  See details and how to joinNCT07519655
• Phase 1Suspended
  A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  Where

  L'Hospitalet de Llobregat, Madrid, Sevilla

  Age

  18 years and over

  People

  460 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT06465069 · EU 2024-512927-36-00
• Phase 2Taking people
  A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  Where

  Barcelona, Las Palmas, Madrid, Málaga, Pamplona, Valencia

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Jazz Pharmaceuticals

  See details and how to joinNCT06695845 · EU 2024-516551-41-00
• Phase 2Taking people
  A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Where

  Barcelona, L'Hospitalet de Llobregat, Madrid

  Age

  18 years and over

  People

  111 worldwide

  Run by

  Bayer

  See details and how to joinNCT06760819 · EU 2024-517419-62-00
• Phase 1Not yet taking people in Spain
  A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  421 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07114601 · EU 2025-522367-15-00
• Phase 1Taking people
  A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  260 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06663319 · EU 2024-516526-66-00
• Phase 2Taking people
  A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

  Where

  Barcelona, Elche, Madrid, Málaga, Ourense, Oviedo, Santander, Valencia

  Age

  18 years and over

  People

  100 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07069712 · EU 2024-516909-23-00
• Phase 1/2Taking people
  A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  Where

  Barcelona, Madrid, Pamplona, Valencia

  Age

  18 years and over

  People

  560 worldwide

  Run by

  Genmab

  See details and how to joinNCT03526835 · EU 2024-513627-16-01
• Phase 1/2Taking people
  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  Where

  Barcelona, Logroño, Madrid, Palma, Zaragoza

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Eikon Therapeutics

  See details and how to joinNCT07262619 · EU 2026-525248-13-00
• Phase 1/2Taking people
  BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  220 worldwide

  Run by

  Bold Therapeutics, Inc.

  See details and how to joinNCT04421820 · EU 2024-517500-11-00
• Phase 1/2Taking people
  A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

  Where

  Barcelona, Madrid, Málaga, PAU de Sanchinarro, Pozuelo de Alarcón, Seville, Valencia

  Age

  18 years and over

  People

  235 worldwide

  Run by

  Alentis Therapeutics AG

  See details and how to joinNCT06747585 · EU 2024-515459-39-00
• Phase 1/2Taking people
  A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  Where

  Barcelona, Madrid

  Age

  18 years and over

  People

  248 worldwide

  Run by

  Terremoto Biosciences Inc.

  See details and how to joinNCT07109726
• Phase 2Taking people
  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  Where

  Barcelona, Madrid, Málaga, Seville, Valencia

  Age

  18 years and over

  People

  740 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06172478 · EU 2023-507641-29-00
• Phase 1/2Taking people
  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Where

  Barcelona, L'Hospitalet de Llobregat, Madrid, Sevilla

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06330064 · EU 2023-509632-26-00
• Phase 3Taking people
  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  Where

  Barcelona, Burgos, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona, Santander, Seville, Valencia

  Age

  18 years and over

  People

  510 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06644781 · EU 2023-509630-19-00